4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-004565
Chief Financial Officer sold 135 shares at $21.41 ($2,890)
- Chief Financial Officer acquired 374 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Firmani Lori Chief Financial Officer | 2026-01-02 | Option exercise | +374 | 1,066 | D | ||
| Firmani Lori Chief Financial Officer | 2026-01-02 | Sale | −135 | $21.41 | $2,890 | 931 | D |
| Derivatives | |||||||
| Firmani Lori Chief Financial Officer | 2026-01-02 | Option exercise · Restricted Stock Units | −374 | 726 | D | ||
| Open-market sales · 135 sh · avg $21.41 · $2,890 | |||||||
Loading xslF345X05/ownership.xml…